Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- Oblong, Inc.
- TAO Synergies Inc.
- PharmaCyte Biotech, Inc.
Updated Jul 16, 2026
SCHECHTER JONATHAN is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $89K. Historical track record: 2/5 stars across 5 tracked purchases.
| Role | Director |
|---|---|
| Notability | 20/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★☆☆☆ (2/5) |
|---|---|
| Total purchases tracked | 5 |
| Purchases with forward-return data | 5 |
| 30-day win rate | 4000% |
| 90-day win rate | 0% |
| Avg 5-day return | +1493.36% |
| Avg 30-day return | -214.31% |
| Avg 90-day return | -1117.50% |
| Best 30-day return | +1129.71% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-07 | PMCB | PharmaCyte Biotech, Inc. | P — Open-market purchase | 20.0K | $0.84 | $17K |
| 2026-01-07 | PMCB | PharmaCyte Biotech, Inc. | P — Open-market purchase | 20.0K | $0.79 | $16K |
| 2026-01-07 | PMCB | PharmaCyte Biotech, Inc. | P — Open-market purchase | 20.0K | $0.78 | $16K |
| 2025-12-12 | PMCB | PharmaCyte Biotech, Inc. | F — Tax withholding / forfeiture | 67.5K | $1.02 | $69K |
| 2025-12-12 | PMCB | PharmaCyte Biotech, Inc. | A — Grant or award | 150.0K | $0.00 | |
| 2025-09-17 | OBLG | Oblong, Inc. | P — Open-market purchase | 5.0K | $2.70 | $13K |
| 2025-09-16 | OBLG | Oblong, Inc. | P — Open-market purchase | 10.0K | $2.73 | $27K |
| 2025-06-30 | TAOX | TAO Synergies Inc. | F — Tax withholding / forfeiture | 8.6K | $7.85 | $68K |
| 2025-06-30 | TAOX | TAO Synergies Inc. | A — Grant or award | 21.6K | $0.00 |
SCHECHTER JONATHAN is a corporate insider — currently tracked as Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 5 open-market purchases ($89K) and 0 open-market sales () across all tracked filings.
Across 5 tracked purchases, SCHECHTER JONATHAN averaged -214.3% avg 30-day return with a 4000% 30-day win rate. InsiderAlpha rates the track record at 2/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SCHECHTER JONATHAN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.